You are here

Article info

Article menu
Download PDFPDF
Editorial
Drugs without benefits? Confronting the challenges of drug-induced interstitial lung disease

Authors

  • Emma K Denneny Centre for Inflammation and Tissue Repair, UCL Respiratory, University College London Division of Medicine, London, UK Interstitial Lung Disease Service, University College London Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Joanna C Porter Centre for Inflammation and Tissue Repair, UCL Respiratory, University College London Division of Medicine, London, UK Interstitial Lung Disease Service, University College London Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Joanna C Porter, Centre for Inflammation and Tissue Repair, UCL Respiratory, University College London Division of Medicine, WC1E 6JF London, UK; joanna.porter{at}ucl.ac.uk
View Full Text

Citation

Denneny EK, Porter JC
Drugs without benefits? Confronting the challenges of drug-induced interstitial lung disease
Thorax 2021;76:1172-1173.

Publication history

  • Accepted July 22, 2021
  • First published August 5, 2021.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.